Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2322
Gene Symbol: FLT3
FLT3 		0.300 Biomarker disease CTD_human Analysis of hematopathology and alteration of JAK1/STAT3/STAT5 signaling axis in experimental myelodysplastic syndrome. 27725143 2016
Entrez Id: 2322
Gene Symbol: FLT3
FLT3 		0.300 Biomarker disease CTD_human Palbociclib treatment of FLT3-ITD+ AML cells uncovers a kinase-dependent transcriptional regulation of FLT3 and PIM1 by CDK6. 27099147 2016
Entrez Id: 4893
Gene Symbol: NRAS
NRAS 		0.300 Biomarker disease CTD_human Analysis of hematopathology and alteration of JAK1/STAT3/STAT5 signaling axis in experimental myelodysplastic syndrome. 27725143 2016
Entrez Id: 3845
Gene Symbol: KRAS
KRAS 		0.300 Biomarker disease CTD_human Analysis of hematopathology and alteration of JAK1/STAT3/STAT5 signaling axis in experimental myelodysplastic syndrome. 27725143 2016
Entrez Id: 324
Gene Symbol: APC
APC 		0.300 Biomarker disease CTD_human Analysis of hematopathology and alteration of JAK1/STAT3/STAT5 signaling axis in experimental myelodysplastic syndrome. 27725143 2016
Entrez Id: 1441
Gene Symbol: CSF3R
CSF3R 		0.300 Biomarker disease CTD_human An activating mutation in the CSF3R gene induces a hereditary chronic neutrophilia. 19620628 2009
Entrez Id: 3553
Gene Symbol: IL1B
IL1B 		0.300 Biomarker disease CTD_human A phase I trial of recombinant human interleukin-1 beta alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer. 1884014 1991
Entrez Id: 3918
Gene Symbol: LAMC2
LAMC2 		0.100 Biomarker disease BEFREE CSF showed mildly elevated opening pressure and lymphocytic pleocytosis and a diagnosis of aseptic meningitis was considered. 30300850 2019
Entrez Id: 1437
Gene Symbol: CSF2
CSF2 		0.100 Biomarker disease BEFREE CSF showed mildly elevated opening pressure and lymphocytic pleocytosis and a diagnosis of aseptic meningitis was considered. 30300850 2019
Entrez Id: 3918
Gene Symbol: LAMC2
LAMC2 		0.100 Biomarker disease BEFREE CSF analysis showed elevated protein of 511 and normal glucose of 104 (67% serum), with lymphocytic pleocytosis (25 cells, 96% lymphocytes). 30430892 2019
Entrez Id: 1437
Gene Symbol: CSF2
CSF2 		0.100 Biomarker disease BEFREE There were no differences between CSF protein, CSF neutrophilic pleocytosis, and serum C-reactive protein between cases and controls (P > 0.1). 30708338 2019
Entrez Id: 3918
Gene Symbol: LAMC2
LAMC2 		0.100 Biomarker disease BEFREE The CSF profile mostly showed mononuclear pleocytosis (64%), high protein (93%) and normal glucose (66%). 31022232 2019
Entrez Id: 3918
Gene Symbol: LAMC2
LAMC2 		0.100 Biomarker disease BEFREE CSF abnormalities usually involved mild pleocytosis. 30482402 2019
Entrez Id: 1437
Gene Symbol: CSF2
CSF2 		0.100 Biomarker disease BEFREE CSF abnormalities usually involved mild pleocytosis. 30482402 2019
Entrez Id: 3918
Gene Symbol: LAMC2
LAMC2 		0.100 Biomarker disease BEFREE CSF showed a monocytic pleocytosis and tested positive for GABA<sub>B</sub> receptor autoantibodies. 31062226 2019
Entrez Id: 1437
Gene Symbol: CSF2
CSF2 		0.100 Biomarker disease BEFREE Moderately increased pleocytosis in CSF (5-100 × 10<sup>6</sup>/L) further increased the diagnostic accuracy of this combination, AUC 0.90 (95% CI, 0.81-0.98). 30669985 2019
Entrez Id: 3918
Gene Symbol: LAMC2
LAMC2 		0.100 Biomarker disease BEFREE CNS viral escape should be considered as a differential among patients on Atazanavir presenting with non-focal cerebral syndrome and CSF lymphocytic pleocytosis. 30951880 2019
Entrez Id: 1437
Gene Symbol: CSF2
CSF2 		0.100 Biomarker disease BEFREE The CSF profile mostly showed mononuclear pleocytosis (64%), high protein (93%) and normal glucose (66%). 31022232 2019
Entrez Id: 1437
Gene Symbol: CSF2
CSF2 		0.100 Biomarker disease BEFREE CSF analysis showed elevated protein of 511 and normal glucose of 104 (67% serum), with lymphocytic pleocytosis (25 cells, 96% lymphocytes). 30430892 2019
Entrez Id: 1437
Gene Symbol: CSF2
CSF2 		0.100 Biomarker disease BEFREE CSF showed a monocytic pleocytosis and tested positive for GABA<sub>B</sub> receptor autoantibodies. 31062226 2019
Entrez Id: 1437
Gene Symbol: CSF2
CSF2 		0.100 Biomarker disease BEFREE CNS viral escape should be considered as a differential among patients on Atazanavir presenting with non-focal cerebral syndrome and CSF lymphocytic pleocytosis. 30951880 2019
Entrez Id: 3918
Gene Symbol: LAMC2
LAMC2 		0.100 Biomarker disease BEFREE There were no differences between CSF protein, CSF neutrophilic pleocytosis, and serum C-reactive protein between cases and controls (P > 0.1). 30708338 2019
Entrez Id: 3918
Gene Symbol: LAMC2
LAMC2 		0.100 Biomarker disease BEFREE Moderately increased pleocytosis in CSF (5-100 × 10<sup>6</sup>/L) further increased the diagnostic accuracy of this combination, AUC 0.90 (95% CI, 0.81-0.98). 30669985 2019
Entrez Id: 1437
Gene Symbol: CSF2
CSF2 		0.100 Biomarker disease BEFREE Additionally, CSF studies showed the transition from a neutrophilic pleocytosis to a lymphocytic pleocytosis suggesting an inflammatory component. 29483006 2018
Entrez Id: 1437
Gene Symbol: CSF2
CSF2 		0.100 Biomarker disease BEFREE Investigation showed: raised CSF protein; pleocytosis; raised CSF:peripheral blood mononuclear cell HTLV-1 proviral load ratio; and MRI either normal or showing white matter changes in brain and cord. 29423617 2018